BackgroundAnemia is a serious public health issue in India with one of the highest prevalence among women of reproductive age (18-49 years) globally. Despite the targeted and concerted efforts, anemia has shown an increasing trend over the past decade. Tripura, one among the Northeastern states of India, has the highest prevalence of WRA in the region at 67.2%. To address this crisis, our research aims to identify the contextual factors affecting anemia in different population groups in Tripura and implement multi-sectoral intervention to address anemia in women of reproductive age group.AimAssess the contextual factors affecting anemia in women of reproductive age (18-49 years) of different population groups (tribal/non-tribal) in Tripura.Co-develop and implement a multisectoral intervention to reduce anemia among women of reproductive age.Research MethodologyA quasi-experimental study design with a mixed method approach is employed. The study will be conducted in four phases -- Formative; Intervention desig

BackgroundSpontaneous intracerebral haemorrhage (ICH) accounts for approximately 10-15% of all strokes but stands for 50% of stroke-related morbidity and mortality. Approximately half of all patients with ICH have a decreased level of consciousness at hospital admission. For many years, randomized clinical trial (RCTs) have failed to establish a specific beneficial treatment after ICH. A study conducted in low- and middle-income countries has demonstrated a beneficial effect of a treatment package consisting of early intensive blood pressure lowering, as well as the treatment of pyrexia and elevated blood glucose levels. The I-CATCHER team is now planning to extend the study in Sweden and Australia, as well as to other high-income countries. AimThis study aims to investigate whether a structured treatment package (Care Bundle) improves 6-month prognosis in patients with spontaneous ICH compared to standard care. Research MethodologyI-CATCHER is an international, multicentre, batc

GlutenSwitchGlutenSwitch helps people living with coeliac disease or a gluten intolerance to identify alternatives that are both gluten-free and similar in healthiness to the scanned item.We have recently launched a new standalone app called GlutenSwitch with added features to help people find foods that are both declared gluten-free by the manufacturer and also foods that we have estimated as gluten-free based on their ingredients. We have also introduced a new feature that allows the user to select the store they are in to show choices that are likely available in their location.The GlutenSwitch app is available in Australia:GlutenSwitch Australia - [Android] [iOS]  FAQsWhat is GlutenSwitch?GlutenSwitch will give you the gluten status of a product, based on if the product is declared gluten-free by the manufacturer or that we have estimated as gluten-free based on their ingredients. GlutenSwitch will also list similar foods that are declared gluten-free and estimated gluten free. You can access th

The ASPIRED Trial will determine the safety and efficacy of low dose aspirin for the prevention of cardiovascular events in people with end stage kidney disease receiving dialysis.